IP Library Granted Patent US 9,149,335
Granted Patent B2
US 9,149,335 · App. 12/951,617 · Granted Oct 6, 2015

Contact free and perforation safe endoluminal laser treatment device and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,149,335
App. No.
12/951,617
Granted
Oct 6, 2015
Kind
B2
Abstract

A device and method for endovascular radiation therapy that prevents unwanted damage to blood vessels during treatment is described. The device is adapted to prevent the emission end of an energy delivery device from coming into contact with the wall of a blood vessel. The device is also adapted to sense the inputted radiation power and prevent irradiation above a preselected power or energy level. Both features serve to prevent radiation, having an overly high intensity or power density, from impacting the vessel wall and causing a puncture.

Claims (5)

1. An endovascular radiation device for treating vascular disorders without causing puncture or perforation to the vessel wall consisting of:

a distancing catheter and

an optical fiber inside of and coaxial with the distancing catheter, connected at its proximal end to an energy source and configured to deliver energy at its distal end;

the distancing catheter having an open-ended flexible catheter tip comprising a distal end defining an open lumen and a securing ring integrally formed in the open-ended flexible catheter tip or secured to an inner surface of the open-ended flexible catheter tip, the securing ring protruding radially from the inner surface of the open-ended flexible catheter tip toward the center of the open-ended flexible catheter tip, the securing ring being configured to secure and center the optical fiber inside the open-ended flexible catheter tip to prevent the optical fiber from diverting radially toward a vessel wall or beyond the distal end of the open-ended flexible catheter tip as the distal end of the optical fiber extends into the open lumen of the open-ended flexible catheter tip without contacting the open-ended flexible catheter tip on the distal side of the securing ring.

2. The device according to claim 1 , wherein said energy source is a laser source.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2016
From: BIOLITEC PHARMA MARKETING LTD.
To: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG
Reel/Frame 041182/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2013
From: CERAMOPTEC INDUSTRIES, INC.
To: BIOLITEC PHARMA MARKETING LTD
Reel/Frame 030963/0272 →